Systemic effects of gut microbiota and its relationship with disease and modulation

BMC Immunology

Volumn 16, Issue 1, 2015, Pages

  Ho, Jolie ^a   Chan, Godfrey ^a   Li, James ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; LAXATIVE; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; VANCOMYCIN; YOGHURT;

ANTIBIOTIC THERAPY; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; BACTERIUM; BIFIDOBACTERIUM; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); COMMENSAL; CROHN DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LIVER CELL CARCINOMA; MENTAL DISEASE; MICROBIAL DIVERSITY; NEOPLASM; NONHUMAN; REVIEW; RISK FACTOR; TISSUE TRANSPLANTATION; ULCERATIVE COLITIS; ANIMAL; AUTOIMMUNE DISEASES; IMMUNOLOGY; INTESTINE MUCOSA; MENTAL DISORDERS; MICROBIOLOGY; NEOPLASMS;

ANIMALS; AUTOIMMUNE DISEASES; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; MENTAL DISORDERS; NEOPLASMS; PREBIOTICS; PROBIOTICS; SYNBIOTICS;

EID: 84928045568     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/s12865-015-0083-2     Document Type: Review

References (42)

1. Koboziev I, Reinoso Webb C, Furr KL, Grisham MB. Role of the enteric microbiota in intestinal homeostasis and inflammation. Free radical biology & medicine. 2014;68:122-33.
2. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiological reviews. 2010;90(3):859-904.
3. Smith K, McCoy KD, Macpherson AJ. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol. 2007;19(2):59-69.
4. Hansen CH, Andersen LS, Krych L, Metzdorff SB, Hasselby JP, Skov S, et al. Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in mice. Journal of immunology. 2014;193(3):1213-22.
5. Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4-14.
6. de Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling GW, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014;57(8):1569-77.
7. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-73.
8. Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, et al. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 2011;43(6):431-8.
9. Verbeke KA, Boesmans L, Boets E. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation? The Proceedings of the Nutrition Society. 2014;73(4):490-7.
10. Walujkar SA, Dhotre DP, Marathe NP, Lawate PS, Bharadwaj RS, Shouche YS. Characterization of bacterial community shift in human Ulcerative Colitis patients revealed by Illumina based 16S rRNA gene amplicon sequencing. Gut pathogens. 2014;6:22.
11. Haag LM, Siegmund B. Exploring & exploiting our 'other self' - does the microbiota hold the key to the future therapy in Crohn's? Best Pract Res Clin Gastroenterol. 2014;28(3):399-409.
12. Hedin C, van der Gast C, Rogers G, McCartney S, Stagg A, Lindsay J, et al. OC-051 Siblings Of Crohn's Disease Patients Exhibit A Biologically Relevant Dysbiosis In The Mucosal Microbial Community: A 16s Rrna Gene Pyrosequencing Study. Gut. 2014;63 Suppl 1:A25.
13. Kennedy N, Walker A, Berry S, Lamb C, Lewis S, Mansfield J, et al. PWE-082 The Impact Of Nod2 Variants On Gut Microbiota In Crohn's Disease And Healthy Controls. Gut. 2014;63 Suppl 1:A159-60.
14. West CE. Gut microbiota and allergic disease: new findings. Curr Opin Clin Nutr Metab Care. 2014;17(3):261-6.
15. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-12.
16. Al-Asmakh M, Anuar F, Zadjali F, Rafter J, Pettersson S. Gut microbial communities modulating brain development and function. Gut microbes. 2012;3(4):366-73.
17. Keller PA, McCluskey A, Morgan J, O'Connor SM. The role of the HPA axis in psychiatric disorders and CRF antagonists as potential treatments. Archiv der Pharmazie. 2006;339(7):346-55.
18. Crumeyrolle-Arias M, Jaglin M, Bruneau A, Vancassel S, Cardona A, Dauge V, et al. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology. 2014;42:207-17.
19. Bonaz B. Inflammatory bowel diseases: a dysfunction of brain-gut interactions? Minerva Gastroenterol Dietol. 2013;59(3):241-59.
20. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720-6.
21. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(38):16050-5.
22. Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013;34(3):1285-300.
23. Baxter NT, Zackular JP, Chen GY, Schloss PD. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome. 2014;2:20.
24. Rogers CJ, Prabhu KS, Vijay-Kumar M. The microbiome and obesity-an established risk for certain types of cancer. Cancer J. 2014;20(3):176-80.
25. Roderburg C, Luedde T. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma. Gut microbes. 2014;5(4):441-5.
26. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer cell. 2012;21(4):504-16.
27. Tillisch K. The effects of gut microbiota on CNS function in humans. Gut microbes. 2014;5(3):404-10.
28. Gomes AC, Bueno AA, de Souza RG, Mota JF. Gut microbiota, probiotics and diabetes. Nutrition Journal. 2014;13:60.
29. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract. 2012;27(2):195-200.
30. Myers-Morales T, Bussell KM, D'Orazio SE. Fecal transplantation does not transfer either susceptibility or resistance to food borne listeriosis in C57BL/6 and BALB/c/By mice. F1000Res. 2013;2:177.
31. Salazar N, Dewulf EM, Neyrinck AM, Bindels LB, Cani PD, Mahillon J, et al. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clinical nutrition. 2014 Jun 11. pii: S0261-5614(14)00159-9.
32. Likotrafiti E, Tuohy KM, Gibson GR, Rastall RA. An in vitro study of the effect of probiotics, prebiotics and synbiotics on the elderly faecal microbiota. Anaerobe. 2014;27:50-5.
33. Andriulli A, Neri M, Loguercio C, Terreni N, Merla A, Cardarella MP, et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. Journal of clinical gastroenterology. 2008;42(Suppl 3 Pt 2):S218-23.
34. Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflammatory bowel diseases. 2013;19(10):2155-65.
35. Brace C, Gloor GB, Ropeleski M, Allen-Vercoe E, Petrof EO. Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. Journal of Crohn's & colitis. 2014;8(9):1133-7.
36. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. The New England journal of medicine. 2013;368(5):407-15.
37. Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, et al. Recovery of the gut microbiome following fecal microbiota transplantation. mBio. 2014;5(3):e00893-14.
38. CRITICAL VIEWS IN GASTROENTEROLOGY & HEPATOLOGY. Fecal microbiota transplantation: where is It leading? Gastroenterol Hepatol (N Y). 2014;10(5):307-9.
39. Aroniadis OC, Brandt LJ. Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. Gastroenterol Hepatol (N Y). 2014;10(4):230-7.
40. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(33):14691-6.
41. Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus. 2014;23(6):518-26.
42. Ianiro G, Bibbo S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Current drug targets. 2014;15(8):762-70.